PTGER3 and cervical carcinoma: Our latest study demonstrated that high expression of EP3 (IRS ≥ 2) is associated with poor prognosis in the OS rate of 250 cervical cancer patients in both squamous cell carcinoma and adenocarcinoma (Heidegger et al. 2017).